DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Wedemeyer et al.
Interim Results of a Multicentre, Open‐Label Phase 2 Clinical Trial (MYR203) to Assess Safety and Efficacy of Myrcludex B in Combination with Peg‐Interferon Alpha 2a in Patients with Chronic HBV/HDV Co‐Infection.
https://aasldpubs.onlinelibrary.wiley.com/doi/10.1002/hep.30256 ; abstract 16, 2018
Search in:
We do not assume any responsibility for the contents of the web pages of other providers.